Francisco Giner | Cancer | Innovative Research Award

Published on by Research Awards

Innovative Research Award

                     Francisco Giner
Affiliation University of Valencia
Country Spain
Scopus ID 24469769300
Documents 67
Citations 666
h-index 16
Subject Area Cancer
Event International Research Awards
ORCID 0000-0003-0765-7120

Francisco Giner

University of Valencia, Spain

Francisco Giner is a researcher affiliated with the University of Valencia whose academic work contributes to cancer research through scientific publications, interdisciplinary collaboration, and evidence-based investigation. His publication record and citation impact demonstrate sustained scholarly engagement, making his profile relevant for consideration within the International Research Awards program.[1]

Abstract

Francisco Giner has established a recognized academic profile through continuous contributions to cancer research at the University of Valencia. His scholarly activities include scientific publications, collaborative investigations, and research focused on improving knowledge within oncology. Supported by a publication record of sixty-seven indexed documents, six hundred sixty-six citations, and an h-index of sixteen, his work reflects measurable scientific influence. These achievements demonstrate sustained research productivity, academic collaboration, and commitment to advancing evidence-based cancer science, supporting his suitability for recognition through the International Research Awards.[1]

Keywords

Cancer Research, Oncology, Scientific Publications, Research Excellence, Innovation, Translational Medicine, Biomedical Science, Scopus, Academic Impact, International Research Awards.

Introduction

Cancer research continues to advance through multidisciplinary investigation, technological innovation, and collaborative scientific discovery. Researchers with consistent publication records contribute to expanding biomedical knowledge while supporting improvements in diagnosis, treatment, and patient outcomes. Francisco Giner’s academic profile reflects these objectives through sustained scholarly engagement and measurable research performance.[1]

Research Profile

As a researcher at the University of Valencia, Francisco Giner has developed expertise within the field of cancer research while contributing to peer-reviewed scientific literature. His Scopus-indexed publication record demonstrates continuous academic productivity, collaborative research involvement, and sustained participation in internationally recognized scientific activities.[1]

Research Contributions

The research contributions associated with Francisco Giner emphasize scientific investigation within oncology and related biomedical disciplines. His published studies support evidence-based understanding while encouraging collaborative research, methodological development, and continued advancement of cancer science through high-quality academic outputs.[2]

Publications

Francisco Giner has produced sixty-seven indexed publications that collectively demonstrate sustained scientific productivity. These publications contribute to the international research community by presenting peer-reviewed findings, supporting collaborative scholarship, and expanding the evidence base within cancer-related scientific investigation.[1]

Research Impact

Citation indicators provide quantitative evidence of research visibility and scholarly influence. Francisco Giner’s citation count and h-index illustrate that his published work has been referenced by other researchers, reflecting continued academic relevance and contribution to the advancement of cancer research literature.[4]

Award Suitability

The Innovative Research Award recognizes sustained academic excellence, research productivity, and meaningful scientific contributions. Francisco Giner’s publication record, citation performance, institutional affiliation, and commitment to cancer research align with commonly recognized indicators considered for international academic recognition programs.[3]

Conclusion

Francisco Giner’s documented research achievements illustrate a consistent commitment to scientific excellence within cancer research. His measurable academic performance, scholarly publications, and research influence collectively support recognition through the International Research Awards while reflecting continued contributions to biomedical science.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Francisco Giner, Author ID 24469769300. Scopus.
    https://www.scopus.com/pages/authors/24469769300
  2. International Research Awards. (n.d.). Innovative Research Award Program.
    https://researchawards.net/
  3. Medina-Ceballos, E., Giner, F., Machado, I., Heras-Morán, B., Espino, M., Navarro, S., & Llombart-Bosch, A. (2025). The prognostic impact of the tumor immune microenvironment in synovial sarcoma: An immunohistochemical analysis using digital pathology and conventional interpretation. Journal of Personalized Medicine, 15(5), 169.
    https://doi.org/10.3390/jpm15050169
  4. Arencibia-Pérez, B., Giner, F., García-Granero, E., Roselló-Keränen, S., Flor-Lorente, B., Cervantes, A., Sancho-Muriel, J., & Frasson, M. (2025). The degree of extramural spread of T3 colon cancer as a prognostic factor: Another appeal to the American Joint Committee on Cancer. Cancer Medicine. Advance online publication.
    https://doi.org/10.1002/cam4.70720
  5. Machado, I., López-Reig, R., Giner, E., Fernández-Serra, A., Requena, C., Llombart, B., Giner, F., Cruz, J., Traves, V., Lavernia, J., Llombart-Bosch, A., & López Guerrero, J. A. (2025). Integration of an OS-based machine learning score (AS score) and Immunoscore as ancillary tools for predicting immunotherapy response in sarcomas. Cancers, 17(15), 2551.
    https://doi.org/10.3390/cancers17152551

Sydney Thai | Geriatric Oncology | Best Researcher Award

Published on by Research Awards

Dr. Sydney Thai | Geriatric Oncology | Best Researcher Award

Post-Doctoral Fellow at CERobs Consulting, United States.

Sydney Thai is a dedicated epidemiologist and researcher specializing in pharmacoepidemiology and real-world evidence. They earned a Ph.D. in Epidemiology from the University of North Carolina at Chapel Hill, preceded by an M.S. in Nutrition from Columbia University and a B.S. in Human Biology from Cornell University. Sydney’s doctoral dissertation focused on frailty screening and impairment patterns in older adults with cancer, using the CARE Registry. Throughout their career, Sydney has held influential roles at organizations like Bristol Myers Squibb and CERobs Consulting, LLC, contributing extensively to studies in aging, oncology, and dermatology. They are recognized for their expertise in healthcare databases, pharmacovigilance, and epidemiological methods. Sydney has also excelled in academia, serving as a teaching assistant and tutor at UNC Chapel Hill and DePaul University, respectively.

Professional Profiles:

Education

Sydney Thai pursued an extensive academic journey culminating in a Ph.D. in Epidemiology from the University of North Carolina at Chapel Hill, completed between 2014 and 2022. His doctoral dissertation focused on “Frailty Screening and Impairment Patterns in Older Adults with Cancer” utilizing data from the Cancer Aging and Resilience Evaluation (CARE) Registry. Prior to his doctoral studies, Sydney completed a Master of Science in Nutrition at Columbia University in 2012, where his thesis explored the role of vitamin A in pancreatic development using embryonic mouse models. He also engaged in graduate studies at DePaul University from 2013 to 2014, delving into Geography, Psychology, Public Health, and Marketing, achieving a GPA of 3.95. Sydney’s academic journey began with a Bachelor of Science in Human Biology, Health & Society from Cornell University, where he graduated in 2011 with a GPA of 3.53, setting a foundation for his subsequent academic achievements and research endeavors in epidemiology and public health.

Professional Experience

Sydney Thai has built a robust professional career marked by significant roles in research and academia. Currently serving as a Post-doctoral Fellow at CERobs Consulting, LLC since 2022, Sydney specializes in real-world data (RWD), real-world evidence (RWE), and Pharmacoepidemiology. Previously, from 2020 to 2022, he held a Pre-doctoral Research Fellowship at Bristol Myers Squibb, focusing on Worldwide Health Economics and Outcomes Research in Immunology, specifically Dermatology and Rheumatology. Prior to this, Sydney worked as a Graduate Research Assistant at CERobs Consulting, LLC from 2018 to 2020, contributing to research in pharmacotherapeutic areas such as biologics, anticholinergic therapies, and opioid treatments. He also gained valuable experience as a Summer Pharmacoepidemiology Intern at Research Triangle Institute (RTI) Health Solutions in 2018. Sydney’s commitment to epidemiology and public health is further evidenced by his teaching and tutoring roles at the University of North Carolina at Chapel Hill, where he assisted in Epidemiology courses and provided academic support. His professional journey underscores a dedication to advancing healthcare research and epidemiological practices.

Teaching Experience

Sydney Thai brings a wealth of academic experience and expertise across multiple institutions. With a Ph.D. in Epidemiology from the University of North Carolina at Chapel Hill, Sydney has served as a dedicated educator and mentor. At UNC Chapel Hill, Sydney excelled as an Academic Enrichment Program Tutor in Epidemiology, guiding students through complex concepts from Fall 2015 to Spring 2019. Sydney’s teaching portfolio also includes roles as a Teaching Assistant for Principles of Epidemiology and Human Development at UNC Chapel Hill and various positions at DePaul University, where Sydney taught courses in psychology and social justice. Beginning at Cornell University, Sydney’s career in education blossomed, culminating in impactful roles as Head Teaching Assistant and Teaching Assistant, demonstrating a deep commitment to fostering learning environments and supporting student growth in public health, psychology, and nutrition disciplines.

Award and Honors

Sydney Thai has excelled in academia and received numerous prestigious honors and awards throughout their educational and professional career. They received the International Society for Pharmacoepidemiology (ISPE) Scholarship to attend the 34th International Conference for Pharmacoepidemiology in Prague, Czech Republic, showcasing their commitment to advancing pharmacoepidemiology globally. At the University of North Carolina at Chapel Hill, Sydney was recognized with the Sidney Kark Award for Distinguished Teaching Assistant in Epidemiology, underscoring their dedication to teaching and mentorship. Their academic prowess was also recognized at DePaul University with the Geography Map of the Month award for their project on “Mapping Pregnancy and Socio-economic Variables Across Chicago.” Additionally, Sydney was inducted into the Order of Omega Greek Leadership Honor Society and named a Meinig Family Cornell National Scholar during their tenure at Cornell University, where they consistently achieved Dean’s List honors. These accolades highlight Sydney’s leadership, academic excellence, and contributions to public health and epidemiology.

Publications

  1. Geriatric Assessment Impairment Profiles and Mortality in Older Adults With Gastrointestinal Cancers: Latent Class Analysis of the CARE Registry
    • Authors: Thai, S.T., Lund, J.L., Kenzik, K.M., Al-Obaidi, M., Williams, G.R.
    • Year: 2024
    • Citations: 0
  2. Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan database
    • Authors: Zhuo, J., Lama, S., Knapp, K., Thai, S., Craig, G.L.
    • Year: 2023
    • Citations: 4
  3. Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey
    • Authors: Thai, S., Barlow, S., Lucas, J., Zhuo, J., Wu, J.J.
    • Year: 2023
    • Citations: 0
  4. Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies
    • Authors: Thai, S., Zhuo, J., Zhong, Y., Priya, L., Wu, J.J.
    • Year: 2023
    • Citations: 5
  5. A systematic review of the patient burden of Crohn’s disease-related rectovaginal and anovaginal fistulas
    • Authors: Iglay, K., Bennett, D., Kappelman, M.D., Karki, C., Cook, S.F.
    • Year: 2022
    • Citations: 2
  6. Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
    • Authors: Zhao, Y., Zhang, J., Zheng, K., Stürmer, T., Wang, T.
    • Year: 2022
    • Citations: 12
  7. Re: Increased Risk of Incident Dementia following Use of Anticholinergic Agents: A Systematic Literature Review and Meta-Analysis
    • Authors: Dmochowski, R.R., Thai, S., Iglay, K., Mudd, P.N., Poole, C.
    • Year: 2022
    • Citations: 0
  8. Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database
    • Authors: Guo, M., Thai, S., Zhou, J., Wang, T., Cui, X.
    • Year: 2021
    • Citations: 5
  9. Re: Increased Risk of Incident Dementia following Use of Anticholinergic Agents: A Systematic Literature Review and Meta-Analysis
    • Authors: Dmochowski, R.R., Thai, S., Iglay, K., Mudd, P.N., Poole, C.
    • Year: 2021
    • Citations: 0
  10. Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer
    • Authors: Shmuel, S., Yang, J.Y., Thai, S., Webster-Clark, M., Lund, J.L.
    • Year: 2021
    • Citations: 0